The Economic Value of Rotavirus Vaccination When Optimally Implemented in a High-Income Country

Rotavirus vaccination was introduced in high-income countries starting in 2006, with no recommendation for optimal implementation. Economic evaluations were presented before launch projecting potential impacts. Few economic reassessments have been reported following reimbursement. This study compare...

Descripción completa

Detalles Bibliográficos
Autor principal: Standaert, Baudouin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10223627/
https://www.ncbi.nlm.nih.gov/pubmed/37243021
http://dx.doi.org/10.3390/vaccines11050917

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10223627/
https://www.ncbi.nlm.nih.gov/pubmed/37243021
http://dx.doi.org/10.3390/vaccines11050917

Ejemplares similares